Skip to main content
Beyond Air, Inc. logo

Beyond Air, Inc. — Investor Relations & Filings

Ticker · XAIR ISIN · US08862L1035 LEI · 549300GFTTTXX5728360 US Manufacturing
Filings indexed 589 across all filing types
Latest filing 2026-04-15 Regulatory Filings
Country US United States of America
Listing US XAIR

About Beyond Air, Inc.

https://www.beyondair.net/

Beyond Air, Inc. is a medical device and biopharmaceutical company focused on developing and commercializing its proprietary LungFit platform. This platform is a nitric oxide (NO) generator and delivery system designed to treat a variety of medical conditions. The core technology generates therapeutic NO on demand from ambient air, which eliminates the need for traditional high-pressure cylinders and their associated logistical complexities. The company's primary focus is on respiratory diseases, with its LungFit PH system being a key product. Beyond Air also maintains a clinical pipeline exploring the application of its technology in other therapeutic areas, including oncology and neurological disorders. The product family includes investigational devices such as LungFit PRO and LungFit GO.

Recent filings

Filing Released Lang Actions
8-K - Beyond Air, Inc. (0001641631) (Filer)
Regulatory Filings
2026-04-15 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
8-K - BEYOND AIR, INC. (0001641631) (Filer)
Regulatory Filings
2026-02-13 English
10-Q Filing
Interim / Quarterly Report Q3 2026
2026-02-13 English
EFFECT - Beyond Air, Inc. (0001641631) (Filer)
Regulatory Filings
2026-02-10 English
424B3 Filing
Prospectus
2026-02-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.